|
THAP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.13670000001509E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.194520E-04 |
| Normal-vs-Stage2 |
2.539000E-01 |
| Normal-vs-Stage3 |
1.12489999981591E-07 |
| Normal-vs-Stage4 |
1.67289999997156E-06 |
| Stage1-vs-Stage2 |
4.268600E-01 |
| Stage1-vs-Stage3 |
2.339500E-02 |
| Stage1-vs-Stage4 |
2.133000E-01 |
| Stage2-vs-Stage3 |
8.715700E-02 |
| Stage2-vs-Stage4 |
2.028600E-01 |
| Stage3-vs-Stage4 |
3.429400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.64859999999267E-05 |
| Normal-vs-AfricanAmerican |
7.16949832835212E-11 |
| Normal-vs-Asian |
8.500000E-01 |
| Caucasian-vs-AfricanAmerican |
3.77910000000092E-05 |
| Caucasian-vs-Asian |
1.524420E-01 |
| AfricanAmerican-vs-Asian |
3.157700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.21330000000198E-05 |
| Normal-vs-Female |
6.50629999876529E-08 |
| Male-vs-Female |
4.439500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.981900E-04 |
| Normal-vs-Age(41-60Yrs) |
1.004020E-03 |
| Normal-vs-Age(61-80Yrs) |
5.81040000002808E-07 |
| Normal-vs-Age(81-100Yrs) |
6.97629999990568E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.209390E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.680600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.107800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.239500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.002800E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.451770E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.520170E-01 |
| Normal-vs-Grade 2 |
2.501000E-03 |
| Normal-vs-Grade 3 |
1.34270000007319E-07 |
| Normal-vs-Grade 4 |
2.47739995185015E-09 |
| Grade 1-vs-Grade 2 |
8.852800E-01 |
| Grade 1-vs-Grade 3 |
2.926600E-01 |
| Grade 1-vs-Grade 4 |
4.192100E-02 |
| Grade 2-vs-Grade 3 |
8.097700E-02 |
| Grade 2-vs-Grade 4 |
6.383600E-04 |
| Grade 3-vs-Grade 4 |
1.399880E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.795900E-02 |
| Normal-vs-ccB subtype |
1.32769999994231E-07 |
| ccA subtype-vs-ccB subtype |
1.101480E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.188570E-04 |
| Normal-vs-N1 |
6.380900E-03 |
| N0-vs-N1 |
6.462800E-01 |
|
|
